|
B-RAF Regulation of the Cell Cycle in Melanoma
|
1R01CA125103-01A2
|
$287,568
|
$287,568
|
APLIN, ANDREW
|
ALBANY MEDICAL COLLEGE
|
|
Molecular Regulation of CIITA Function by GTP-Binding
|
5K01CA095582-05
|
$149,175
|
$149,175
|
HARTON, JONATHAN
|
ALBANY MEDICAL COLLEGE
|
|
Production and use of Pb-203 for cancer therapy research
|
2R44CA114920-02A2
|
$397,597
|
$397,597
|
MOORE, HERBERT
|
ALPHAMED, INC
|
|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
$455,098
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$4,812
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA
|
2R01CA086832-06A2
|
$279,192
|
$279,192
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Repression by C SKI and Melanoma Progression
|
5R01CA084282-08
|
$264,568
|
$264,568
|
MEDRANO, ESTELA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$4,691
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$60,600
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancement of Dendritic Cells for Improved Immunotherapy
|
5R01CA120411-03
|
$258,529
|
$51,706
|
SPENCER, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Antigen specificity, suppressive mechanism & regulation of CD4+ regulatory T cell
|
5R01CA116408-03
|
$258,529
|
$258,529
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-07
|
$985,145
|
$788,116
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-10
|
$292,811
|
$146,406
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
|
1R01CA129350-01A2
|
$526,521
|
$526,521
|
PALUCKA, A
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$4,533
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies
|
1R01CA129339-01A1
|
$352,750
|
$88,188
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
1K08CA129204-01A1
|
$135,270
|
$67,635
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma
|
1K99CA133245-01
|
$131,790
|
$131,790
|
Zheng, Bin
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Novel Treatment to Target Tumor Mass for Eradicating Metastasis
|
1R43CA130182-01A1
|
$200,435
|
$200,435
|
Bao, Yun
|
BIOCHAIN INSTITUTE, INC.
|
|
Applying nanosecond pulse electric fields to treat skin cancer
|
1R01CA125722-01A2
|
$216,697
|
$108,349
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
Development of a nanosecond pulsed electric field system to treat skin cancer
|
1R43CA123924-01A2
|
$200,016
|
$200,016
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
DEVELOPMENT OF AN ELECTRICAL DIAGNOSTIC FOR MELANOMA
|
5R44CA117227-03
|
$838,256
|
$838,256
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
3R01CA112102-04S1
|
$54,979
|
$27,490
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
5R01CA112102-04
|
$302,435
|
$151,218
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
|
1R01CA138231-01
|
$319,045
|
$319,045
|
Frank, Markus
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma
|
1R01CA122838-01A2
|
$360,688
|
$360,688
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Prospective study of telomere length and melanoma risk
|
1R03CA133914-01
|
$87,778
|
$87,778
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Pigmentation Genes and Skin Cancer Risk
|
5R03CA128080-02
|
$87,500
|
$28,875
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Immunological Mediator Genes and Skin Cancer Risk
|
5R03CA132175-02
|
$86,936
|
$29,558
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
2P50CA093683-06A2
|
$2,300,000
|
$1,840,000
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Population-Based Approach to Skin Cancer Epidemiology
|
5K07CA108978-03
|
$138,820
|
$138,820
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nitric Oxide Synthase Polymorphisms and Risk for Skin Cancer
|
5R03CA130055-02
|
$87,500
|
$28,875
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Carbohydrate-Dependent Adhesion in Normal and Tumor Cells
|
2P01CA071932-11A2
|
$1,410,599
|
$56,424
|
FUKUDA, MINORU
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Characterization of JNK in Cell Cycle Control
|
1R01CA138143-01A2
|
$396,325
|
$198,163
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Function of ATF2 URE Binding Protein in Human Melanoma
|
5R01CA051995-17
|
$369,117
|
$369,117
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Novel Insights in the regulation of HIF1alpha Stability
|
5R01CA111515-05
|
$371,262
|
$148,505
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
ATF2 in DNA damage response.
|
5R01CA117927-03
|
$451,222
|
$225,611
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-28
|
$3,649,220
|
$218,953
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
NanoSystems Biology Cancer Center
|
5U54CA119347-04
|
$3,546,396
|
$354,640
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-25
|
$855,703
|
$8,557
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-18S3
|
$234,254
|
$2,343
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S1
|
$72,416
|
$724
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-19S2
|
|
$0
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-19
|
$5,104,000
|
$51,040
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Modulating Base Excision Repair in Tumor Drug Resistance
|
5R01CA086357-09
|
$261,129
|
$86,173
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Molecular studies of T cell clones for adoptive therapy
|
5K23CA109115-03
|
$134,460
|
$67,230
|
Kim, Julian
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
2U10CA052352-19
|
$575,627
|
$5,756
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Semaphorin 3F: Structure, Function, and Anti-Metastatic Activity
|
5K01CA118732-03
|
$159,300
|
$79,650
|
BIELENBERG, DIANE
|
CHILDREN'S HOSPITAL BOSTON
|
|
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
|
5R01CA113796-03
|
$291,276
|
$291,276
|
Frank, Markus
|
CHILDREN'S HOSPITAL BOSTON
|
|
Cancer Biology in the Zebrafish
|
2R01CA103846-06
|
$367,235
|
$183,618
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
Total relevant funding to Melanoma for this search: $110,789,716
|